Regenerative Medicine Market – Global Outlook and Forecast 2022-2028

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body?s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or “regenerating” human cells, tissues or organs to restore or establish normal function and has been called the “next evolution of medical treatments” and ?the vanguard of 21st century healthcare? by the U.S. Department of Health and Human Services.

This report contains market size and forecasts of Regenerative Medicine in Global, including the following market information:

  • Global Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

The global Regenerative Medicine market was valued at 34340 million in 2021 and is projected to reach US$ 111830 million by 2028, at a CAGR of 18.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Regenerative Medicine include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics and Osiris Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Regenerative Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)

  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other

Global Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)

  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others

Global Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Regenerative Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Regenerative Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • J & J (DePuy Synthes)
  • Medtronic
  • Zimmer Biomet
  • Stryker
  • Allergan(Acelity)
  • MiMedx Group
  • Organogenesis
  • Fujifilm Cellular Dynamics
  • Osiris Therapeutics
  • Vcanbio
  • CCBC
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • AMAG Pharmaceuticals (CBR)
  • ViaCord
  • CordLife
  • Integra LifeSciences
  • Nuvasive
  • Cook Biotech
  • Japan Tissue Engineering

Table of content

1 Introduction to Research & Analysis Reports
1.1 Regenerative Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Regenerative Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Regenerative Medicine Overall Market Size
2.1 Global Regenerative Medicine Market Size: 2021 VS 2028
2.2 Global Regenerative Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Regenerative Medicine Players in Global Market
3.2 Top Global Regenerative Medicine Companies Ranked by Revenue
3.3 Global Regenerative Medicine Revenue by Companies
3.4 Top 3 and Top 5 Regenerative Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Regenerative Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Regenerative Medicine Players in Global Market
3.6.1 List of Global Tier 1 Regenerative Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Regenerative Medicine Companies
4 Market Sights by Product
4.1 Overview

North Main Road Koregaon Park, Pune, India – 411001.
International: +1(646)-781-7170
Asia: +91 9169162030

Follow Us On linkedin :-

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button